Anxiety
Mental health experts are sounding the alarm as a new study reveals the alarming rate of shame-related disorders in patients with atopic dermatitis and psoriasis. The research, conducted by a team of dermatologists and psychologists at the University Medical Center Rostock in Germany, aimed to investigate the prevalence and correlates
Advertising executives
A new study conducted by researchers from National Defense Medical Center has found a significant association between atopic dermatitis (AD) and increased risk of fibromyalgia. The study, published in the Indian Journal of Dermatology, Venereology and Leprology, analyzed data from the Taiwan National Health Insurance Research Database and found that
Atopic dermatitis
Research led by Inner Mongolia University of Science and Technology in Baotou, People's Republic of China, has shed light on the intricate mechanisms of mast cell regulation in skin inflammation. The study, published in Frontiers in Immunology, uncovered the functional heterogeneity of mast cells and their distinct inflammatory
Advertising executives
A new study conducted by researchers from National Defense Medical Center has found a significant association between atopic dermatitis (AD) and increased risk of fibromyalgia. The study, published in the Indian Journal of Dermatology, Venereology and Leprology, analyzed data from the Taiwan National Health Insurance Research Database and found that
Atopic dermatitis
Research led by Inner Mongolia University of Science and Technology in Baotou, People's Republic of China, has shed light on the intricate mechanisms of mast cell regulation in skin inflammation. The study, published in Frontiers in Immunology, uncovered the functional heterogeneity of mast cells and their distinct inflammatory
Atopic dermatitis
Research has shown that Atopic Dermatitis, a chronic inflammatory skin condition, affects 10-30% of children and 2-10% of adults in developed countries. A recent study explored the psychosocial impact of AD, focusing on the relationship between stress biomarkers and disease severity. The study found a significant positive correlation between cortisol
Atopic dermatitis
Research has shown that Atopic Dermatitis, a chronic inflammatory skin condition, affects 10-30% of children and 2-10% of adults in developed countries. A recent study explored the psychosocial impact of AD, focusing on the relationship between stress biomarkers and disease severity. The study found a significant positive correlation between cortisol
Atopic dermatitis
Studies have shown that dupilumab, a biologic treatment for atopic dermatitis, can be an effective treatment for both resolving skin conditions and reducing the risk of psychiatric comorbidities. However, a recent study has highlighted the potential for dupilumab to contribute to acute mood episodes in rare cases, particularly in patients
Atopic dermatitis
Researchers at the University of Arizona College of Medicine have published new findings on the racial and ethnic disparities in global atopic dermatitis clinical trials. Their study, published in the journal Dermatology, found that despite growing awareness of the impact of atopic dermatitis on skin of color patients, the majority
Atopic dermatitis
Current research results on skin diseases and conditions - atopic dermatitis have been published, reevaluating the cellular sources of IL-13, a key effector cytokine in AD lesions. This review reappraises the traditional paradigm of CD4 Th2 cells as the primary producers of IL-13 in AD, instead highlighting the substantial contribution
Atopic dermatitis
Fresh data on Skin Diseases and Conditions - Atopic Dermatitis has been presented in a new report from Milan, Italy. The research, conducted by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, aimed to investigate the effectiveness and safety of lebrikizumab, a biologic drug targeting interleukin-13, in a predominantly white
Atopic dermatitis
Fresh data on Skin Diseases and Conditions - Atopic Dermatitis has been presented in a new report from Milan, Italy. The research, conducted by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, aimed to investigate the effectiveness and safety of lebrikizumab, a biologic drug targeting interleukin-13, in a predominantly white
